Javier Pinilla‐Ibarz

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma”.

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-23-0056

N/A

0.557DataRank · unranked

40 citations

Sae Bom Lee, Michael D. Jain, Biwei Cao, Xuefeng Wang, Kai Rejeski +28 more

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel

Cancer Medicine(2021)10.1002/cam4.3664

N/A

0.538DataRank · unranked

35 citations

Reena Jayani, Aaron Collier, Nathaly Irizarry‐Arroyo, Yvelise Rodriguez, Michael D. Jain +17 more

Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice

Journal of Clinical Investigation(2020)10.1172/jci135711

N/A

0.396DataRank · unranked

13 citations

Jairo Pérez‐Sanz, Tara Lee Costich, Kyle K. Payne, Carmen M. Anadon, Ricardo A. Chaurio +13 more

Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.09.013

N/A

0.241DataRank · unranked

4 citations

Anna Barata, Xiaoyin Li, Nathaly Irizarry‐Arroyo, Michael D. Jain, Taylor Welniak +19 more

Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes

Blood Advances(2021)10.1182/bloodadvances.2020003475

N/A

0DataRank · unranked

40 citations

Kathy L. McGraw, Farnoosh Abbas‐Aghababazadeh, Benjamin S. Meyer, Amy F. McLemore, Nicole D. Vincelette +14 more

Loss of AID exacerbates the malignant progression of CLL

Leukemia(2022)10.1038/s41375-022-01663-5

N/A

0DataRank · unranked

1 citations

Sai Ravi Pingali, Javier Pinilla‐Ibarz, Michael L. Atchison, Constantinos Koumenis, Yair Argon +5 more

Utilization of immortalized B cells to identify SDCBP as a novel therapeutic target in ovarian carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e14507

N/A

0DataRank · unranked

0 citations

Sumit Mehta, Alexandra Martin, Subir Biswas, Kamira Maharaj, Jessica A. Mine +14 more

Survival trends among patients diagnosed with both melanoma and chronic lymphocytic leukemia.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19527

N/A

0DataRank · unranked

0 citations

Rossybelle P. Amorrortu, Sandra C. Stewart, Kavita Ghia, Vonetta L. Williams, Vernon K. Sondak +5 more

Sézary syndrome originates from heavily mutated hematopoietic progenitors

Blood Advances(2023)10.1182/bloodadvances.2022008562

N/A

0DataRank · unranked

15 citations

Kimberly B. Sprenger, Ricardo A. Chaurio, John J. Powers, Patrick Innamarato, Carmen M. Anadon +15 more

Trial in Progress: A Phase 1b Study of AS-1763, an Oral, Potent and Selective Noncovalent BTK Inhibitor, in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Blood(2023)10.1182/blood-2023-182568

N/A

0DataRank · unranked

1 citations

James D’Olimpio, Andew gillis-Smith, Seung‐Tae Lee, Nirav N. Shah, Javier Pinilla‐Ibarz +9 more

Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model

Blood Advances(2025)10.1182/bloodadvances.2024014822

N/A

0DataRank · unranked

12 citations

Nienke B. Goedhart, Helga Simon‐Molas, Melanie Mediavilla-Varela, Angimar Uriepero-Palma, Fleur S. Peters +11 more

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3815

N/A

0DataRank · unranked

116 citations

Lindsey E. Roeker, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Danielle M. Brander +49 more

Lymphoma accelerates T cell and tissue aging

Cancer Cell(2025)10.1016/j.ccell.2025.07.023

N/A

0DataRank · unranked

10 citations

Joshua Davis, Komal J Handoo, Aya G. Elmarsafawi, Anthony C. Augello, Chia‐Ho Cheng +21 more

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

Blood Advances(2020)10.1182/bloodadvances.2020001800

N/A

0DataRank · unranked

63 citations

John J. Powers, Alex Achille, Melanie Mediavilla-Varela, Wael Gamal, Karen L. Burger +11 more

Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.12.025

N/A

0DataRank · unranked

10 citations

Ambuj Kumar, Hamza Hashmi, Franco Garcia, Constantine Logothetis, Alicia Darwin +14 more

STING regulates BCR signaling in normal and malignant B cells

Cellular and Molecular Immunology(2020)10.1038/s41423-020-00552-0

N/A

0DataRank · unranked

39 citations

Avery C. Lee, Shiun Chang, Qin Xu, Andong Shao, Yun Lo +5 more